Physician profile
Kovi E Bessoff
NPI 1144616806
$5,555.92
in general payments reported to CMS, 2019-2025
9 companies · $2,254 in 2025
The $2,254 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $156 · 2023: $333 · 2024: $2,813 · 2025: $2,254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,972 · Food and Beverage: $2,086 · Education: $333 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,972.11 |
| Food and Beverage | $2,086.17 |
| Education | $333.16 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,348.58 | 2023-2024 | Progrip, Signia, Ligasure |
| Davol INC. | $1,844.40 | 2024-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $713.88 | 2022-2025 | |
| W. L. Gore & Associates, INC. | $210.38 | 2024 | Gore Synecor Biomaterial |
| Ethicon US, LLC | $144.79 | 2025 | Vistaseal, Surgicel Nu-Knit, Dermabond Prineo |
| Prytime Medical Devices, INC. | $111.94 | 2025 | Er-Reboa Plus |
| Boston Scientific Corporation | $96.85 | 2025 | Spyglass Discover, Spyglass |
| Tela Bio, INC. | $47.59 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbott Laboratories | $37.51 | 2024 | 2nd Gen Centrimag Primary Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kovi Bessoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.